drugset / Trial / NCT06910098
Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels
RandomizedParallel-groupDouble-blindPrevention
Summary
Particpants were divided into groups based on doses of rosuvastatin and were assessed and for CPK, LDL and AST levels
Timeline
- Start
- 2023-12-01
- Primary completion
- 2024-06-30
- Completion
- 2024-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rosuvastatin | Small molecule | 5 mg | — |
| Comparator | Rosuvastatin | Small molecule | 10 mg | — |
| Comparator | Rosuvastatin | Small molecule | 20 mg | — |